Cholesterol homeostasis in pathogenesis of DR
Cholesterol homeostasis in pathogenesis of DR
批准号:
10693905
负责人:
Julia V Busik
金额:
$38.88万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2025-08-31
关键词:
AffectArterial Fatty StreakBloodBlood VesselsBlood-Retinal BarrierBone MarrowCCL2 geneCellsCholesterolCholesterol HomeostasisChoroidChronicCirculationComplementComplement ActivationCoupledCrystal FormationCyclodextrinsCytochrome P450DehydrationDevelopmentDiabetes MellitusDiabetic RetinopathyDiseaseDyslipidemiasEndotheliumEthanolExcisionExtracellular SpaceForeign BodiesFundingGenesImmune systemImmunohistochemistryInfiltrationInflammasomeInflammationInflammation MediatorsInflammatoryInnate Immune SystemIntercellular adhesion molecule 1Interleukin-1 betaLectinLipidsLocationMacrophageMasksMediatingMicrogliaMusNeural RetinaPathogenesisPathogenicityPathologyPathway interactionsPatientsPhotoreceptorsPhysiologicalProductionPrognostic MarkerPublishingRepressionRetinaSIRT1 geneScanning Electron MicroscopyShapesSourceStructureStructure of retinal pigment epitheliumTestingTissuesX ray spectroscopycell injurycellular developmentcomplement pathwaycytokinediabeticextracellularhuman subjectin vivolipid metabolismmonocytenovelpharmacologicpreventrepairedretinal damagetissue preparationtissue processing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Disruptions in cholesterol homeostasis and metabolism can lead to high cholesterol
concentrations in diseased tissue and the formation of cholesterol crystals (CC). CC are often
overlooked in traditional histo/immunohistochemistry as the ethanol, used for tissue processing,
can dissolve them. This masks CC presence and potential involvement in pathogenic
mechanisms. Using Scanning Electron Microscopy (SEM) of tissues prepared without an
ethanol dehydration step, we identified the presence of CC: i) in “lipid pools” between retinal
pigment epithelium (RPE) and photoreceptors (PR); ii) circulating freely in diabetic murine
blood; and iii) within circulating monocytes of diabetic human subjects. Since CC are very stable
physiologically and are not easily amenable to dissolving in vivo, they become a source of
chronic inflammation. CC are recognized by the innate immune system as foreign bodies
because of their shape, firmness, and inability to be dissolved. Moreover, CC also induce
inflammation via the NLRP3 inflammasome activation. These novel preliminary and published
studies have led us to propose the following hypothesis (see schematic in Fig.1): Diabetes-
induced disruption of i) systemic cholesterol homeostasis, ii) blood retinal barrier function; and
iii) SIRT1, LXR and CYP46A1 expression alters retinal cholesterol homeostasis leading to
CC formation within key locations: RPE, PR, monocytes/macrophages, and in the circulation
affecting the endothelium. This CC formation results in intra- and extracellular complement
activation and priming of the NLRP3 inflammasome for its activation and release of highly
damaging pro-inflammatory cytokines, promoting development of DR. To test this hypothesis,
we propose the following Specific Aims: Aim1: To determine the temporal changes in retinal
cholesterol accumulation that lead to CC formation. Aim 2: To test the hypothesis that diabetes-
induced cholesterol accumulation and CC formation in the retina and in
monocytes/macrophages induces activation of intracellular and extracellular complement to
trigger the NLRP3 inflammasome and IL-1β production. Aim 3: To test the hypothesis that LXR
activation and direct sequestration of cholesterol by alpha-cyclodextrin can inhibit CC-induced
complosome and NLRP3 inflammasome formation in the diabetic retina and in
monocytes/macrophages cells, thus preventing chronic inflammation and development of DR.
Impact: The successful completion of this project will result in identifying an entirely novel
pathway in which CC-induced complosome and NLRP3 inflammasome formation that can be
pharmacologically targeted to prevent DR.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.visres.2017.04.010
发表时间:
2017-10
期刊:
Vision research
影响因子:
1.8
作者:
[Hammer SS, Busik JV]
通讯作者:
Busik JV
DOI:
10.2337/db17-1587
发表时间:
2018-08
期刊:
Diabetes
影响因子:
7.7
作者:
[Huang C, Fisher KP, Hammer SS, Navitskaya S, Blanchard GJ, Busik JV]
通讯作者:
Busik JV
DOI:
10.1016/j.chemphyslip.2021.105090
发表时间:
2021-08
期刊:
Chemistry and physics of lipids
影响因子:
3.4
作者:
[Hossain M, Blanchard GJ]
通讯作者:
Blanchard GJ
Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
COVID-19受试者中的血浆微生物组:肠道屏障缺陷和营养不良的指标。
DOI:
10.3390/ijms23169141
发表时间:
2022-08-15
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[]
通讯作者:
DOI:
10.1016/j.chemphyslip.2021.105091
发表时间:
2021-08
期刊:
Chemistry and physics of lipids
影响因子:
3.4
作者:
[Hossain M, Blanchard GJ]
通讯作者:
Blanchard GJ
共 14 条
Anti-ceramide immunotherapy for diabetic retinopathy
-
批准号:10440369
-
项目类别:
-
资助金额:$38.02万
-
财政年份:2019
-
负责人:Julia V Busik
-
依托单位:
Anti-ceramide immunotherapy for diabetic retinopathy
-
批准号:10200072
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2019
-
负责人:Julia V Busik
-
依托单位:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
-
批准号:9904655
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2018
-
负责人:Julia V Busik
-
依托单位:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
-
批准号:10132325
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2018
-
负责人:Julia V Busik
-
依托单位:
Cholesterol homeostasis in pathogenesis of DR
-
批准号:10226319
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2015
-
负责人:Julia V Busik
-
依托单位:
Cholesterol homeostasis in pathogenesis of DR
-
批准号:10542239
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2015
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10478284
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10659205
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:6984993
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:7271200
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:9037380
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8197250
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:7104937
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10297108
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:9188561
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8374409
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8585067
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8041939
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and retinal endothelial cell dysfunction
-
批准号:6758620
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2003
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and retinal endothelial cell dysfunction
-
批准号:6674628
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2003
-
负责人:Julia V Busik
-
依托单位: